Variant report
Variant | esv1800894 |
---|---|
Chromosome Location | chr11:93683635-93691161 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:93684701..93687298-chr11:93690286..93693320,3 | K562 | blood: | |
2 | chr11:93687985..93689849-chr11:93692203..93693783,2 | K562 | blood: | |
3 | chr11:93680099..93683642-chr11:93684474..93688848,4 | K562 | blood: | |
4 | chr11:93691026..93692794-chr11:93694188..93696052,2 | K562 | blood: | |
5 | chr11:93680099..93683642-chr11:93684474..93688848,4 | K562 | blood: | |
6 | chr11:93684701..93687298-chr11:93690286..93693320,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181469661 | chr11:93684001-93684002 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543904582 | chr11:93684047-93684048 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184699961 | chr11:93684083-93684084 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188621732 | chr11:93684084-93684085 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs548040420 | chr11:93684170-93684171 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549849050 | chr11:93684187-93684188 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2511398 | chr11:93684809-93684810 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs151214920 | chr11:93684812-93684813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs564304130 | chr11:93684847-93684848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2460057 | chr11:93684902-93684903 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs550261047 | chr11:93684938-93684939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs568483610 | chr11:93684985-93684986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7942236 | chr11:93685031-93685032 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs908749 | chr11:93685035-93685036 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs566279867 | chr11:93685056-93685057 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs201731770 | chr11:93685068-93685069 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs139746131 | chr11:93685087-93685088 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558071078 | chr11:93685102-93685103 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs145262999 | chr11:93685163-93685164 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536359469 | chr11:93685196-93685197 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555809480 | chr11:93685237-93685238 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574170304 | chr11:93685317-93685318 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577168934 | chr11:93685374-93685375 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201116454 | chr11:93685422-93685423 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs201352889 | chr11:93685424-93685425 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs67487531 | chr11:93685425-93685426 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs553341678 | chr11:93685436-93685437 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186997042 | chr11:93685472-93685473 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs67915626 | chr11:93685473-93685474 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs564138681 | chr11:93685499-93685500 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs147612201 | chr11:93685519-93685520 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567836191 | chr11:93685560-93685561 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562193236 | chr11:93685565-93685566 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192504584 | chr11:93685598-93685599 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs60539088 | chr11:93685604-93685605 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs12792941 | chr11:93685640-93685641 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs533465162 | chr11:93685715-93685716 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552016384 | chr11:93685726-93685727 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570177083 | chr11:93685768-93685769 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74493003 | chr11:93685784-93685785 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs398076147 | chr11:93685785-93685786 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs182853373 | chr11:93685832-93685833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555522888 | chr11:93685833-93685834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567854130 | chr11:93685898-93685899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531272343 | chr11:93685944-93685945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535172254 | chr11:93685974-93685975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551299828 | chr11:93685981-93685982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs2008041 | chr11:93686002-93686003 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs142113075 | chr11:93686020-93686021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs545796695 | chr11:93686050-93686051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21499728 | CNVD |
Breast cancer | 19181860 | CNVD |
Breast cancer | 17603634 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:93684000-93684200 | Bivalent Enhancer | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr11:93684800-93686400 | Enhancers | HepG2 | liver |
3 | chr11:93685000-93685800 | Bivalent Enhancer | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr11:93687000-93687800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr11:93689000-93691600 | Enhancers | Brain Germinal Matrix | brain |
6 | chr11:93690000-93690200 | Enhancers | Pancreas | Pancrea |
7 | chr11:93690000-93691200 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr11:93690600-93690800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr11:93690800-93691000 | Enhancers | Fetal Muscle Leg | muscle |
10 | chr11:93691000-93691400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |